{"jobs":[{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/6009595004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5160405004,"location":{"name":"Boston, MA"},"metadata":null,"id":6009595004,"updated_at":"2026-05-29T18:29:11-04:00","requisition_id":"235","title":"Director, CMC Program Management - Drug Product","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-05-29T18:29:11-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Centessa is seeking a Director of CMC Program Management for Drug Product. The CMC PM will provide leadership and operational support to the development and manufacturing of our small molecule programs and actively engage with internal teams and external contract manufacturing organizations.\u0026amp;nbsp; The individual will drive effective execution of CMC deliverables by the project teams in coordination with and support of program and corporate goals.\u0026amp;nbsp; The ideal candidate should be highly organized and an exceptional communicator with experience leading early phase pre-IND teams through late-stage CMC Registration/Commercial validation and launch activities.\u0026amp;nbsp; Travel to vendors both domestically and internationally will be required.\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Serve as the main point of contact for all CMC project-related communications especially focused on drug product development, manufacturing, release, packaging, labeling, and stability coordination\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Foster strong relationships with internal teams, and external partners including CDMOs.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Participate in regular telecon meetings with CDMOs to maintain the business relationship, progress, meeting notes and action items.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Monitor timelines and contracts for accuracy and follow up on any discrepancies with contractors and/or internal personnel.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Support CMC activities including tracking relevant GMP and Regulatory documentation.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Interfaces with drug substance, drug product, analytical, non-clinical, clinical, Regulatory, supply chain, and Quality colleagues to ensure all projects are delivered on time, within scope and budget.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Work with CMC team members to identify resource constraints, risks, and conflicts that could impact the team’s bandwidth and/or company timelines.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Cover all other project management requirements including shipment/logistics coordination, inventory, and production planning.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Drive the development and management of detailed and integrated development plans for CMC projects that account for all phases of drug development across functions with timelines, work plans including interdependencies, gating items, budget, and risk management strategies.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Oversee the delivery of project objectives per the program strategy, with a strong focus on meeting critical milestones, and managing scope changes while integrating project constraints.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Facilitate effective collaboration across CMC functional teams, ensuring alignment on project goals and priorities.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Communicate project updates consistently to various stakeholders, about strategy, adjustments, and development progress.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Experience utilizing project management tools and best practices to support CMC activities.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Excellent attention to detail, communication, time management, organizational skills, and flexible attitude to work assignments and new learning with proven ability to interact in a team environment.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Comfortable in a fast-paced small company environment with the ability to manage a variety of projects simultaneously and handle rapidly changing information.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Project management professional (PMP) certification preferred.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Expert MS Office skills including Excel, PowerPoint, MS Project, and other PM timeline software (e.g. Smartsheet).\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026amp;nbsp;\u0026lt;/strong\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;10+ years of pharmaceutical industry experience, including 7+ years leading CMC project/program management activities\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proven experience in small molecule drug development, with emphasis on drug product development and manufacturing \u0026lt;em\u0026gt;required\u0026lt;/em\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong understanding of the end-to-end drug development process, including CMC, non-clinical, clinical, and regulatory activities\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated knowledge of CMC requirements across all phases of clinical development\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Thorough understanding of cGMP regulations for pharmaceutical products\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Experience coordinating and managing CDMO activities supporting development and commercialization\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong project management, organizational, and prioritization skills to manage multiple, evolving programs\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Excellent decision-making, analytical, and resource management skills in dynamic, global environments\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Effective communicator with the ability to clearly convey complex scientific information both verbally and in writing\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ability to work independently while collaborating cross-functionally and with stakeholders at all organizational levels\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Self-motivated, results-driven, adaptable to changing priorities, and willing to travel domestically and internationally\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026amp;nbsp;\u0026lt;/strong\u0026gt;\u0026lt;strong\u0026gt;Compensation\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for this level is $210,000.00 to $240,000.00. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus. Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Director CMC Program Management, Drug Product role is based in the US, with domestic and international travel.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt;\u0026amp;nbsp;Full-Time, Exempt\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4020617004,"name":"Technical Operations","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/5821396004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5060644004,"location":{"name":"Boston, MA"},"metadata":null,"id":5821396004,"updated_at":"2026-05-14T16:44:08-04:00","requisition_id":"218","title":"Executive Director, Clinical Development","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-05-04T14:44:58-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Executive Director, Clinical Development will play a critical leadership role in advancing Centessa’s clinical programs in sleep-wake disorders and broader CNS indications. Reporting directly to the Senior Vice President, Clinical Development, this leader will assume primary responsibility for the strategic and operational execution of the company’s late-stage Orexin Receptor 2 Agonist Program (Program 750), which targets narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Given the broad pipeline within the organization, the Senior Director must bring deep experience spanning preclinical through late-stage clinical development, with the ability to shift fluidly across programs as priorities change.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In this highly visible, hands-on role, the Executive Director will collaborate closely with cross-functional partners across Clinical Operations, Regulatory Affairs, Translational Medicine, Biometrics, Safety, and external stakeholders. The individual will provide scientific and medical leadership for clinical study design, execution, data interpretation, and regulatory interactions. This role requires a collaborative and agile mindset, exceptional communication skills, and the ability to influence across a matrixed organization.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;em\u0026gt;This position is ideal for those seeking:\u0026lt;/em\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;The opportunity to lead a late-stage asset with the potential to transform standard of care for individuals living with sleep-wake disorders\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;A role within a lean, fast-paced, growth-oriented biotech environment requiring deep CNS expertise\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;A collaborative, science-driven, and patient-focused culture\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;A remote working environment with high visibility and strategic impact\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Serve as a senior clinical leader for \u0026lt;strong\u0026gt;Program 750\u0026lt;/strong\u0026gt;, providing medical and scientific leadership for late-stage development while maintaining readiness to support earlier-stage or emerging programs.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Author and oversee clinical study protocols for orexin receptor agonists, ensuring scientific rigor, operational feasibility, and alignment with regulatory expectations.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Contribute to and help develop integrated clinical development plans (CDPs) spanning \u0026lt;strong\u0026gt;preclinical translation through late-stage trials\u0026lt;/strong\u0026gt;, enabling efficient advancement of multiple candidate molecules.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Collaborate closely with Clinical Operations to meet quality, timeline, and budget expectations across all studies within the 750 program and other CNS programs as needed.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide real-time medical and scientific guidance for ongoing clinical trials, including data review, safety oversight, and acceleration of development programs.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Partner with Translational Medicine to support biomarker strategy, dose selection, and evaluation of indication of expansion opportunities.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Engage effectively with investigators, KOLs, and external experts to ensure Centessa’s orexin agonist programs remain at the forefront of scientific and clinical innovation.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Communicate clinical and scientific updates across internal teams and external stakeholders.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Contribute to the preparation, authorship, and review of clinical sections of regulatory submissions, including INDs, protocol amendments, briefing documents, annual reports, safety reports, and clinical study reports.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ensure robust oversight of safety monitoring and adherence to \u0026lt;strong\u0026gt;Good Clinical Practice (GCP)\u0026lt;/strong\u0026gt;, pharmacovigilance standards, internal SOPs, and quality requirements.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Support regulatory interactions with global health authorities, including preparation for key meetings, responses, and ongoing communication.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide senior oversight of study integrity, safety, efficacy data, and risk-benefit assessments across assigned programs.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ensure that clinical insights and external evidence are synthesized and used to guide strategic decision-making across the portfolio.\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;MD in neurology/neuroscience required; board certification required (includes internationally recognized equivalent); MD/PhD strongly preferred\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Minimum 10 years of combined professional experience in CNS therapeutic areas academia, clinical practice, and/or the pharmaceutical or biotech industry\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Minimum 5 years of pharma or biotech industry experience with demonstrated leadership of: Clinical development programs, global clinical trials and clinical science organizations\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Deep expertise in CNS therapeutic areas, with direct experience in sleep disorders\u0026amp;nbsp;\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Proven people and line management experience within a pharma/biotech environment\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Willingness to deliver project and tactical level work\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Excellent working knowledge of regulations across various agencies (FDA, EMA, etc.) and GCP, \u0026amp;amp; ICH guidelines. \u0026amp;nbsp;Knowledge or experience supporting regulatory or health authority inspections a plus.\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Experience leading and authoring clinical development inputs into regulatory submissions (IND, CTAs, NDA/BLAs, designation applications, etc.) and representing clinical development in agency interactions.\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Experience authoring and guiding teams with key asset and clinical trial level plans and documents.\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Strong knowledge in clinical development strategy, clinical trial design, regulatory pathways, biostatistics methodologies, and ability to analyze and interpret translational medicine, clinical, and research data as it relates to an asset, patients, etc.\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Possess excellent written and oral communication skills with internal and external stakeholders\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Proven ability to work collaboratively, take initiative, solve complex issues, and deliver results in a fast-paced, team-based matrix environment\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Demonstrate sound judgement in handling complex, confidential, and highly regulated information\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Ability and willingness to travel as required.\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for this position is $300,000 to $375,000. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus and participation in our equity program, allowing you to share in Centessa’s long-term success.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Executive Director, Clinical Development role is based in the US, with occasional travel.\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4068209004,"name":"Clinical Development","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/5972135004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5143404004,"location":{"name":"Boston, MA"},"metadata":null,"id":5972135004,"updated_at":"2026-05-07T17:46:11-04:00","requisition_id":"225","title":"Executive Director, Head of Toxicology","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-04-17T10:15:12-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Centessa Pharmaceuticals is seeking\u0026amp;nbsp;an\u0026amp;nbsp;Executive Director/Head of Toxicology\u0026amp;nbsp;to\u0026amp;nbsp;provide\u0026amp;nbsp;scientific and strategic leadership for nonclinical safety across discovery and development programs, with an emphasis on\u0026amp;nbsp;small\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;molecule\u0026amp;nbsp;therapeutics. This role leads toxicology and safety pharmacology strategy to support target\u0026amp;nbsp;selection, lead optimization,\u0026amp;nbsp;IND\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;enabling\u0026amp;nbsp;activities, and clinical advancement. Reporting\u0026amp;nbsp;to our\u0026amp;nbsp;SVP, Nonclinical \u0026amp;amp; Translational Development\u0026lt;/span\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;em\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;,\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/em\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;the\u0026amp;nbsp;Head of Toxicology partners closely with\u0026amp;nbsp;cross\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;functional\u0026amp;nbsp;teams and\u0026amp;nbsp;represents\u0026amp;nbsp;nonclinical safety in regulatory interactions while building a strong,\u0026amp;nbsp;high\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;performing\u0026amp;nbsp;toxicology organization.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Lead and mentor a team of toxicologists and technical/operational staff, fostering scientific excellence and professional growth\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Define and execute nonclinical safety strategies across discovery, preclinical, and clinical stages\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide expert toxicology and safety pharmacology input to cross‑functional development teams\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Lead nonclinical sub‑teams as an integrated development head, providing cross‑functional oversight across Toxicology, DMPK, Bioanalytical Sciences, and Clinical Pharmacology to ensure aligned, program‑ready nonclinical strategies\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Serve as the primary nonclinical representative on Program Development Teams (PDTs) and at internal governance and external forums, effectively championing program strategy, presenting to regulatory authorities, and holding scientific ground with senior leadership, partners, CROs, and health authorities\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Design, oversee, and interpret GLP, non‑GLP, investigative, and in vitro toxicology studies\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Develop safety strategies for new targets, lead optimization programs, and platform technologies\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Oversee toxicology and safety pharmacology studies conducted internally and at CROs\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ensure high scientific quality, compliance, and timely delivery of nonclinical study outputs\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Author and critically review toxicology sections of regulatory documents (e.g., pre‑IND, IND, IBs)\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Partner with biology, DMPK, pathology, pharmacology, clinical, and regulatory colleagues to drive integrated decision‑making\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Present nonclinical safety data and risk assessments to project teams and senior R\u0026amp;amp;D leadership\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Serve as the primary nonclinical safety representative in regulatory agency interactions\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Support product defense and regulatory submissions through robust scientific rationale\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide strategic guidance on safety issue resolution and investigational toxicology approaches\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Contribute to portfolio‑level planning and prioritization of nonclinical safety resources\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Build scalable toxicology capabilities to support a growing and diverse pipeline\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;PhD in Toxicology, Pharmacology, Pathology, DVM, or related discipline; board certification (e.g., DABT, ERT) - required\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;18+ years of experience in pharmaceutical or biotechnology R\u0026amp;amp;D with a strong track record in nonclinical and regulatory toxicology\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proven ability to function as an upward‑facing nonclinical leader and generalist, with the credibility and judgment to represent project development team agenda at decisional governance meetings, engage confidently with regulatory agencies, and serve as a trusted development partner to senior leadership\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Deep expertise supporting small‑molecule programs across discovery, IND‑enabling, and early clinical development\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong working knowledge of national and international GLP guidelines\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated experience defining and executing nonclinical safety strategies to support diverse pipelines and novel biology\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proven leadership experience building, managing, and mentoring toxicology teams within a collaborative, matrixed environment\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Extensive experience preparing and reviewing nonclinical sections of global regulatory submissions and engaging with health authorities (FDA, EMA)\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong ability to integrate complex nonclinical datasets across toxicology, pathology, DMPK, and pharmacology to inform development decisions\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Experience overseeing outsourced toxicology and safety pharmacology studies and managing CRO partnerships\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Excellent communication and influencing skills, with the ability to partner effectively across Early Development, Research, and Regulatory functions in a fast‑paced environment\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Compensation\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;The annual base salary range for this position is $320,000.00 to $350,000.00. Individual compensation within this range will be\u0026amp;nbsp;determined\u0026amp;nbsp;based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus.\u0026lt;/span\u0026gt; \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;span class=\u0026quot;TextRun SCXW146193423 BCX0\u0026quot; lang=\u0026quot;EN-US\u0026quot; data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW146193423 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;The\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW146193423 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;Executive Director, Head of\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW146193423 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;Toxicology\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW146193423 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;\u0026amp;nbsp;role\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW146193423 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;\u0026amp;nbsp;is a remote role based in the US, with occasional travel\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW146193423 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;.\u0026lt;/span\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;EOP SCXW146193423 BCX0\u0026quot; data-ccp-props=\u0026quot;{\u0026amp;quot;134233117\u0026amp;quot;:false,\u0026amp;quot;134233118\u0026amp;quot;:false,\u0026amp;quot;201341983\u0026amp;quot;:0,\u0026amp;quot;335557856\u0026amp;quot;:16777215,\u0026amp;quot;335559738\u0026amp;quot;:0,\u0026amp;quot;335559739\u0026amp;quot;:360,\u0026amp;quot;335559740\u0026amp;quot;:240}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt; Full-Time, Exempt\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4094537004,"name":"Non-Clinical","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/5727515004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5015198004,"location":{"name":"Boston, MA"},"metadata":null,"id":5727515004,"updated_at":"2026-05-07T17:11:33-04:00","requisition_id":"179","title":"Executive Director, Regulatory CMC","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2025-12-03T15:30:08-05:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Executive Director, Regulatory CMC will provide strategic leadership for global CMC regulatory activities across all stages of drug development and life cycle management. Reporting to the SVP, Regulatory and Medical Writing, this role serves as a liaison to health authorities, driving regulatory strategies, overseeing high-quality submissions, and ensuring compliance with FDA, EMA, and ICH guidelines. The position requires deep expertise in small molecule development, strong cross-functional collaboration, and the ability to influence organizational policies and processes in a fast-paced, growing environment. The ideal candidate combines strategic vision with hands-on leadership to deliver innovative, compliant solutions that accelerate development and commercialization.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Provide overall regulatory CMC strategy for drug development programs and life cycle management, ensuring alignment with corporate objectives and timelines.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Serve as a spokesperson and trusted liaison with FDA and other health authorities, leading negotiations and presenting CMC positions effectively.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Develop de-risking strategies for CMC development, assess change controls, and identify opportunities to accelerate development in a dynamic environment.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Lead creation and execution of comprehensive CMC development plans for new products, ensuring integration with Technical Operations and external partners.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Partner with supply chain, clinical operations, and manufacturing teams to ensure readiness and compliance for clinical and commercial supply.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Oversee preparation and quality of all CMC regulatory submissions (INDs, BLAs, MAAs, DMFs, IMPDs, amendments, annual reports), providing strategic direction and ensuring global compliance.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Drive the development and implementation of departmental policies, SOPs, and best practices to support scalability and operational excellence in a growing organization.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Interpret and communicate regulatory CMC requirements and expectations to internal teams and external partners to ensure program objectives are met.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Contribute to corporate initiatives aimed at improving regulatory standards, systems, and processes across the organization.\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Master’s degree in chemistry, pharmaceutical sciences, or a related scientific field (PharmD or PhD preferred).\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Minimum 15 years in the pharmaceutical industry, including at least 7 years in Regulatory CMC.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated experience across early-stage, late-stage development, and life cycle management for small molecule products.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Comprehensive understanding of FDA, EMA, and ICH CMC guidelines, regulatory requirements, and current Good Manufacturing Practices (cGMP).\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proven experience preparing and submitting CMC regulatory documents (e.g., INDs, IMPDs, CTAs, NDA\u0026#39;s, MAAs) and leading successful interactions with health authorities such as FDA and EMA.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Track record of developing and executing CMC regulatory strategies, balancing near-term objectives with long-term goals.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong leadership skills with the ability to work effectively in a matrixed environment; excellent verbal and written communication skills to articulate regulatory viewpoints to diverse audiences.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ability to thrive in a fast-paced, collaborative environment and comfortable with both strategic planning and hands-on execution.\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Compensation\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for this \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;job level \u0026lt;/span\u0026gt;is $285,000 - $350,000. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus. Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Executive Director, Regulatory CMC role is based in the US, with occasional travel.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt; Full-Time, Exempt\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4085824004,"name":"Regulatory","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/5972582004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5143622004,"location":{"name":"Boston, MA"},"metadata":null,"id":5972582004,"updated_at":"2026-05-04T15:44:58-04:00","requisition_id":"227","title":"Senior Director, Clinical Pharmacology","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-04-21T17:29:47-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Centessa is seeking an experienced Senior Director, Clinical Pharmacology to provide scientific and strategic leadership for clinical pharmacology across a diverse pipeline spanning early development through late-stage and registrational programs. Reporting to the Executive Director, Clinical Pharmacology, this position is accountable for developing and executing clinical pharmacology strategies that address the unique challenges of neuroscience drug development, including CNS exposure, dose optimization, and translational relevance. The Senior Director partners closely with cross-functional teams and represents clinical pharmacology in regulatory interactions to enable efficient, data-driven advancement of therapies across our neuroscience portfolio.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;\u0026lt;span data-contrast=\u0026quot;none\u0026quot;\u0026gt;Lead clinical pharmacology strategy for CNS and neuroscience programs from\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;first\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;in\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;human\u0026amp;nbsp;through registrational and\u0026amp;nbsp;post\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;marketing\u0026amp;nbsp;stages\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Design, execute, and interpret clinical pharmacology studies, including FIH, multiple‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;ascending\u0026amp;nbsp;dose, DDI, biopharmaceutics, and patient studies\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Drive dose selection and optimization by integrating PK, PD, safety, efficacy, and CNS‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;specific\u0026amp;nbsp;biomarkers\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Lead model‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;informed\u0026amp;nbsp;drug development, including population PK, PK/PD, and exposure–response analyses relevant to CNS targets\u0026amp;nbsp;and clinical safety\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Assess and guide strategies for CNS exposure, brain penetration, target engagement, and translational biomarkers \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Serve as the clinical pharmacology lead on program teams, clinical sub‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;teams, and trial working groups\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Author and oversee clinical pharmacology sections of regulatory documents (e.g., INDs, CTAs, IBs, NDAs) \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Represent clinical pharmacology in interactions with FDA and other global health authorities, supporting dose justification and labeling discussions \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Partner closely with DMPK, Translational Sciences, Clinical Development, Biomarkers, Biostatistics, CMC, and Regulatory Affairs \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Oversee CROs and external vendors conducting clinical pharmacology and modeling activities \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Ensure timely communication and clear interpretation of clinical pharmacology results to internal stakeholders\u0026amp;nbsp;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Contribute to portfolio strategy, program prioritization, risk mitigation, and long‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;range\u0026amp;nbsp;clinical development planning for CNS assets\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Serve as a subject‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;matter\u0026amp;nbsp;expert on clinical pharmacology\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Mentor and develop clinical pharmacology talent as the pipeline and organization grow \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Ensure high‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;quality,\u0026amp;nbsp;submission\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;ready\u0026amp;nbsp;documentation aligned with global regulatory standards\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;PhD, PharmD, or MD in Clinical Pharmacology, Pharmacokinetics, Pharmaceutical Sciences, or a related discipline\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;8–12+ years of experience in clinical pharmacology within biopharma, with demonstrated impact in clinical drug development\u0026amp;nbsp;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Extensive experience developing and executing clinical pharmacology strategies for early‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;through\u0026amp;nbsp;late\u0026lt;/span\u0026gt;‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;stage\u0026amp;nbsp;programs, including registrational support\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Strong expertise in PK, PD, PK/PD integration, exposure–response analyses, and drug–drug interaction assessment\u0026amp;nbsp;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Demonstrated experience applying quantitative clinical pharmacology approaches (e.g., population PK, mechanistic PK/PD modeling) to inform CNS dose selection and optimization \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Proficiency with clinical pharmacology tools and platforms such as NONMEM, R, Phoenix WinNonlin, SimCyp, or equivalent\u0026amp;nbsp;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Experience authoring and delivering clinical pharmacology components of regulatory submissions (e.g., INDs, CTAs, NDAs) and interacting with global health authorities \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Strong understanding of translational PK, CNS exposure considerations, and biomarker integration in neuroscience drug development \u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;10\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:360,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;hybridMultilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;16\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Excellent communication, collaboration, and leadership skills with the ability to operate effectively in a fast‑\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;paced, matrixed environment\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Compensation\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;The annual base salary range for this position is $270,000.00 to $295,000.00. Individual compensation within this range will be\u0026amp;nbsp;determined\u0026amp;nbsp;based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus.\u0026lt;/span\u0026gt; \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;span class=\u0026quot;TextRun SCXW102698544 BCX0\u0026quot; lang=\u0026quot;EN-US\u0026quot; data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW102698544 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;The\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW102698544 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;Senior Director, Clinical\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW102698544 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;Pharmacology\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW102698544 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;\u0026amp;nbsp;role\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW102698544 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;\u0026amp;nbsp;is a remote role based in the US, with occasional travel\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;NormalTextRun SCXW102698544 BCX0\u0026quot; data-ccp-parastyle=\u0026quot;Normal (Web)\u0026quot;\u0026gt;.\u0026lt;/span\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;span class=\u0026quot;EOP SCXW102698544 BCX0\u0026quot; data-ccp-props=\u0026quot;{\u0026amp;quot;134233117\u0026amp;quot;:false,\u0026amp;quot;134233118\u0026amp;quot;:false,\u0026amp;quot;201341983\u0026amp;quot;:0,\u0026amp;quot;335557856\u0026amp;quot;:16777215,\u0026amp;quot;335559738\u0026amp;quot;:0,\u0026amp;quot;335559739\u0026amp;quot;:360,\u0026amp;quot;335559740\u0026amp;quot;:240}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt; Full-Time, Exempt\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4094537004,"name":"Non-Clinical","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/6007349004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5159218004,"location":{"name":"Boston, MA"},"metadata":null,"id":6007349004,"updated_at":"2026-05-27T14:42:42-04:00","requisition_id":"233","title":"Senior Director, Toxicology (CNS Specialist) ","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-05-27T13:25:14-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Centessa is seeking a Senior Director, Toxicology to provide scientific and technical leadership for nonclinical safety in our CNS programs. Reporting to the SVP, Nonclinical \u0026amp;amp; Translational Development, the Senior Director will drive program-level toxicology strategy from target selection and lead optimization through IND-enabling activities, clinical advancement, and NDA submission, with a particular focus on CNS small molecules. The successful candidate will work independently to direct their own program work, provide day-to-day scientific guidance to entry-level toxicology staff, and collaborate closely with peers across nonclinical and development functions. The Senior Director will own design, oversight, and interpretation of toxicology and safety pharmacology studies executed at CROs and will author the toxicology contributions to global regulatory submissions.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Define and execute nonclinical safety strategies for assigned small molecule CNS programs across discovery, IND-enabling, and clinical development stages.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Develop safety strategies for new CNS targets, lead optimization programs, and platform technologies.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proactively identify gaps and emerging risks within assigned programs and implement risk mitigation plans, engaging external experts as appropriate.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Maintain a current understanding of scientific literature and regulatory guidance relevant to CNS toxicological assessment, and sustain a professional network of external subject matter experts to inform program strategy.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Design, oversee, and interpret GLP, non-GLP, investigative, and in vitro toxicology and safety pharmacology studies, with emphasis on endpoints and models relevant to CNS-active small molecules.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Lead outsourcing efforts for the design, monitoring, execution, and reporting of nonclinical toxicology studies, ensuring scientific quality, regulatory compliance, and timely delivery.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Manage and monitor outsourced toxicology and safety pharmacology studies at external CROs, interacting effectively with CRO study directors throughout study conduct.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Critically review and edit nonclinical study reports and coordinate report finalization with CROs.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Integrate complex nonclinical datasets across toxicology, pathology, DMPK, and pharmacology to inform candidate selection and program decisions.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Author and critically review the toxicology sections of global regulatory documents, including pre-IND packages, INDs, CTAs, IBs, DSURs, and NDA submissions.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Prepare science-based written responses to nonclinical inquiries from health authorities (FDA, EMA, and other global regulators).\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Collaborate closely with peers in biology, DMPK, pathology, pharmacology, clinical, regulatory, and CMC to ensure toxicology activities and findings are integrated into overall program plans.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide day-to-day scientific direction and mentorship to entry-level toxicology staff supporting assigned programs.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Work independently to plan, prioritize, and deliver on program toxicology objectives.\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;PhD in Toxicology, Pharmacology, Pathology, Neuroscience, DVM, or related discipline; board certification (e.g., DABT, ERT).\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;13+ years of pharmaceutical or biotechnology R\u0026amp;amp;D experience with a strong track record in nonclinical and regulatory toxicology.\u0026amp;nbsp;\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Substantial experience supporting \u0026lt;strong\u0026gt;CNS / neuroscience drug development \u0026lt;/strong\u0026gt;(required).\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Deep expertise supporting small molecule programs across discovery, IND-enabling, and early clinical development, with demonstrated experience advancing CNS-active candidates.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated experience serving as the toxicology lead on cross-functional drug development programs.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Extensive experience authoring and reviewing nonclinical sections of global regulatory submissions (IND/CTA/IB/DSUR/NDA) and preparing written responses to health authority inquiries.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong working knowledge of FDA, EMA, and ICH guidance documents and GLP regulations, with a solid understanding of how QA, regulatory, and clinical functions interface with nonclinical safety assessment.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated success leading outsourcing and oversight of toxicology and safety pharmacology studies and managing CRO study directors and partnerships.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong ability to integrate complex nonclinical datasets across toxicology, pathology, DMPK, and pharmacology to inform development decisions.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proven ability to work independently, set priorities, and deliver high-quality program output without close supervision, while collaborating effectively with peers across functions.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Excellent verbal communication and scientific writing skills as applied to study reports and regulatory documents.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Sense of urgency, detail orientation, and ability to thrive in a hands-on, growth stage environment.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Able and willing to travel regularly (up to 25% - 30% of the time).\u0026amp;nbsp;\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Compensation\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for this position is 275,000.00 to $300,000.00. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus. Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Senior Director, Head of Toxicology based in the US, with regular travel (up to 25% - 30%).\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt;\u0026amp;nbsp;Full-Time, Exempt\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4094537004,"name":"Non-Clinical","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/5671419004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":4989394004,"location":{"name":"Boston, MA"},"metadata":null,"id":5671419004,"updated_at":"2026-05-04T15:46:36-04:00","requisition_id":"168","title":"Senior Medical Science Liaison (MSL) - Northeast","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2025-10-07T18:34:48-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Sr. MSL will serve as a field-based scientific expert responsible for engaging with healthcare professionals (HCPs), supporting clinical development, and ensuring alignment with Centessa’s strategic medical objectives. This role is critical in translating complex scientific data into meaningful clinical insights and fostering compliant, evidence-based dialogue with thought leaders.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;em\u0026gt;Scientific Expertise \u0026amp;amp; Thought Leader Engagement\u0026lt;/em\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Maintain a high level of therapeutic area expertise and scientific knowledge relevant to Centessa’s pipeline and marketed products in alignment with Medical Affairs strategic objectives\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Engage in compliant, non-promotional scientific exchange with key opinion leaders (KOLs), investigators, and other HCPs\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Serve as a trusted scientific resource to external stakeholders, providing accurate and balanced medical information\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Deliver company-approved, high-quality medical/scientific presentations to a variety of audiences including formulary committees and healthcare professionals.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide medical/scientific support for critical Centessa activities including speaker training, advisory boards, and sales training as appropriate\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ensure accurate, timely, and compliant documentation of field-based activities in accordance with MSL organization guidelines\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;em\u0026gt;Clinical Trials Support\u0026lt;/em\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Collaborate with Clinical Operations to identify and evaluate potential clinical trial sites and investigators based on scientific expertise, patient population, and alignment with study objectives\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide scientific education and protocol-specific training to investigators and site staff during site initiation visits, ensuring thorough understanding of study rationale and endpoints\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Maintain ongoing engagement with trial sites and investigators to facilitate successful execution of clinical trial objectives, provide ongoing scientific support, address protocol-related inquiries, and ensure high-quality data generation\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;em\u0026gt;Medical Conference Attendance \u0026amp;amp; Coverage\u0026lt;/em\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Attend relevant scientific and medical congresses to stay current with emerging data and trends\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Provide real-time insights and post-conference reports to internal teams\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Support Centessa’s presence at congresses through development of pre-conference plans, booth coverage, symposia participation, and KOL engagement\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Senior MSLs will be responsible to leading strategic conference planning, execution, and reporting\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;em\u0026gt;Scientific Materials Development\u0026lt;/em\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Contribute to the development of scientific slide decks, FAQs, and educational materials\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Writing and editing Medical Information response letters\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ensure all materials are medically accurate, evidence-based, and compliant with regulatory standards\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Collaborate with Medical Affairs and Legal teams to ensure scientific content meets internal and external guidelines\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;em\u0026gt;Additional Responsibilities:\u0026lt;/em\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Lead MSL strategic initiatives/projects aligned with Medical Affairs and MSL organization strategy\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Develop and implement scientific training plans for the MSL team\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Contribute to MSL organization strategy in collaboration with MSL leadership\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Mentorship of MSL peers\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Advanced degree (PhD, PharmD, MD, DP, PsyD, DNP) in life sciences or a related field (from An Accredited College or University).\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Minimum 4+ years\u0026#39; experience as an MSL for a drug development company in the pharmaceutical/biotech industry\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated understanding of sleep medicine and/or associated neuroscientific areas required\u0026amp;nbsp;\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Exceptional verbal and written communication skills; ability to tailor scientific messages to diverse audiences and ability to interpret and communicate complex scientific data\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proven ability to build and maintain strong relationships with KOLs, investigators, and internal stakeholders\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong understanding of clinical trial design, regulatory requirements, and therapeutic area landscape\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Skilled in developing and delivering scientific presentations in various settings\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong understanding of industry regulations and guidelines governing medical interactions\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ability to align field activities with broader medical and corporate strategies\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Senior MSLs have a proven ability to lead and mentor peers\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Must have a valid driver’s license with a driving record that meets company requirements\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;\n\u0026lt;div\u0026gt;Must reside within the New England region or the New York Metro area.\u0026lt;/div\u0026gt;\n\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Willing and able to travel frequently within assigned territory (\u0026lt;em\u0026gt;Boston, New York, Philadelphia, Baltimore, Detroit, Cleveland, Cincinnati\u0026lt;/em\u0026gt;)\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Compensation\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for the Senior MSL job level is $190,000 - $230,000.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Individual compensation within these ranges will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus. Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Sr. MSL - Northeast is a remote role based in the US, with up to 60-70% travel and occasional weekends\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt; Full-Time, Exempt\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4086810004,"name":"Medical Affairs","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/5972186004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5143435004,"location":{"name":"Boston, MA"},"metadata":null,"id":5972186004,"updated_at":"2026-04-29T14:24:46-04:00","requisition_id":"226","title":"Senior Scientist, DMPK","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-04-17T11:38:04-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Centessa is seeking a Senior Scientist in Discovery DMPK to partner with pharmacologists and medicinal chemists to support the identification of lead candidates with optimal DMPK properties for potential progression into development. Reporting to the Executive Director, DMPK, this role requires understanding of pharmacokinetic (PK), pharmacodynamic/pharmacokinetic (PK/PD), and ADME principles to enable triaging \u0026amp;amp; progression of small molecule leads. \u0026lt;strong\u0026gt;A qualified candidate will have previous experience in PK and PK/PD modeling, ideally for CNS drug candidates, and an understanding of vital ADME properties for CNS drug candidate progression\u0026lt;/strong\u0026gt;.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Design profiling strategies (including in vitro ADME assays) to evaluate compounds and series emerging from hit identification effort\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Design PK/PD strategies to advance lead identification and optimization series\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Protocol development and data analysis of PK and PK/PD studies for proof-of-concept studies\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Review statements of work (SOWs) to ensure alignment with project objectives\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Analyze and interpret in vitro and in vivo PK and PK/PD data, ensuring accuracy and consistency\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Utilize AI tools in prediction of PK properties and guide the use of such technology in supporting SAR development in lead identification and optimization phases\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Author and review compound checklists for drug candidate progression\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Represent the DMPK function in project team meetings; present results and contribute to data-driven decision-making.\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Ph.D. in Pharmaceutical Sciences, Pharmacology or a related field\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Minimum of 4 years of industry experience in a biotech or pharmaceutical setting\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proficiency with Phoenix WinNonlin and other software for PK and PK/PD modeling in small molecule drug discovery is essential\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Previous work in the early discovery and lead optimization of CNS drug candidates is essential\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong analytical and problem-solving skills\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated ability to work cross-functionally and communicate scientific findings clearly and effectively\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Collaborative mindset and sense of urgency\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proactive and excellent communication skills\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Compensation\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for this position is $160,000 - $180,000. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus and participation in our equity program, allowing you to share in Centessa’s long-term success.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Sr. Scientist, DMPK is a remote role based in the US, with infrequent travel (~10%).\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt; Full-Time, Exempt\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4094537004,"name":"Non-Clinical","child_ids":[],"parent_id":null}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/6004771004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5158213004,"location":{"name":"Boston, MA"},"metadata":null,"id":6004771004,"updated_at":"2026-05-22T16:29:33-04:00","requisition_id":"232","title":"Vice President, Global Team Leader ","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-05-22T16:29:33-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;As Centessa continues to progress our Orexin portfolio, we are looking for a Vice President, Global Team Leader. The Global Team Leader will report to the SVP of Global Program Leadership. The successful candidate will work across multiple functions in the organization including research, pre-clinical and clinical development.\u0026amp;nbsp; This is a highly visible leadership role which will be empowered to set program strategy to advance the product to approval and beyond.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Assemble, manage and lead one or more high functioning cross-functional program teams. Provide leadership through effective project management, strong goal setting, well managed team meetings and develop and oversee the integrated plan deliverables\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Set tone and culture of project team and relevant sub teams; set program vision and strategy, and ensure team delivers per plan\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Work directly with the team to identify all cross-functional dependencies and constraints and facilitate resolution activities to achieve the desired outcomes\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Lead the team in preparation and approval of development plans, budgets, and proposed go/no-go decision criteria for development programs\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Work frequently with senior management to ensure transparency is maintained and to resolve resourcing and strategic options across functions to ensure efficient design and flawless execution of the development plan to maximize the value of the program\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Monitor the day-to-day interactions with project core and ad hoc team members from various functions (Clinical Development, Clinical Operations, Regulatory Affairs, Research, CMC, Finance, etc.)\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Utilize communication abilities –both written planning and the ability to organize issues and areas that need to be elevated within the plan\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Interface with regulatory authorities, as well as internal and external stakeholders as required or directed (such as investors, science and physician scientist leaders, leadership or BOD) in support of the development objectives\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Design and implement fit-for-purpose product development teams appropriate for size and stage of program including sub-teams and/or external support when needed\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Work with Program Manager to prepare project timelines for all activities, resources, and costs to accomplish key milestone dates and build into the project schedule\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Management for one or more direct reports within program management function\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Advanced professional degree in life sciences (PhD, PharmD, MD, MBA)\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;At least 15 years’ experience in the pharmaceutical and/or biotechnology industry, \u0026lt;em\u0026gt;the majority of which should be in team leadership, portfolio or program management\u0026lt;/em\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;2-5 years line management experience\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Product development experience in CNS therapeutic area preferable, though not required\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Experience leading cross functional teams, particularly project teams\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Experience in early and late phase development, including IND/NDA filings\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Knowledge of nonclinical, clinical, regulatory and manufacturing aspects of drug development\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Experience working on small molecule development programs preferred\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Direct involvement with vendor/CRO management\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Able and willing to travel up to 25% of the time\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Compensation\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for this position is $325,000.00 to $375,000.00. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus. Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The \u0026lt;strong\u0026gt;Vice President, Global Team Leader \u0026lt;/strong\u0026gt;role is based in the US, with 20% - 25% travel.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt;\u0026amp;nbsp;Full-Time, Exempt\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4020622004,"name":"Program Management","child_ids":[],"parent_id":4020616004}],"offices":[]},{"absolute_url":"https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/5816705004","data_compliance":[{"type":"gdpr","requires_consent":false,"requires_processing_consent":false,"requires_retention_consent":false,"retention_period":null,"demographic_data_consent_applies":false}],"internal_job_id":5058297004,"location":{"name":"Boston, MA"},"metadata":null,"id":5816705004,"updated_at":"2026-05-04T15:48:47-04:00","requisition_id":"213","title":"Vice President, Pharmacovigilance \u0026 Safety ","company_name":"Centessa Pharmaceuticals, LLC","first_published":"2026-05-04T09:30:29-04:00","language":"en","application_deadline":null,"content":"\u0026lt;div class=\u0026quot;content-intro\u0026quot;\u0026gt;\u0026lt;p\u0026gt;Centessa Pharmaceuticals plc (Nasdaq: CNTA) new kind of pharmaceutical company with a deconstructed R\u0026amp;amp;D environment that prioritizes data driven decision making led by subject matter experts. Centessa is advancing a portfolio of high conviction programs with strong biological validation.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;Our asset-centric model offers a unique R\u0026amp;amp;D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026amp;nbsp;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Description of Role\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;div\u0026gt;The Vice President, Global Medical Safety / Pharmacovigilance will serve as the global leader for drug safety, providing strategic vision and medical oversight across all pharmacovigilance and risk management activities. This role is responsible for leading pre- and post-marketing safety activities across all phases of clinical development (Phase I–IV) and post-approval, ensuring proactive benefit–risk assessments, regulatory compliance, and the highest standards of patient safety. The VP will drive an integrated, science-driven global safety strategy for the company’s small molecule pipeline, working closely with internal stakeholders and teams, as well as global health authorities. In addition, this role will oversee departmental operations, including organizational planning, budgeting, and the development of scalable pharmacovigilance capabilities to support a growing biotech organization.\u0026lt;/div\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Key Responsibilities\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Strategic Leadership \u0026amp;amp; Oversight\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;1\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Develop and execute a\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;comprehensive pharmacovigilance (PV) strategy\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;aligned with corporate\u0026amp;nbsp;objectives\u0026amp;nbsp;and regulatory expectations.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;1\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Lead \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;safety governance\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;and benefit-risk management for small molecule assets across development and post-marketing.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;1\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Ensure compliance with \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;global PV regulations\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;(FDA, EMA, ICH, MHRA, etc.).\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;1\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Provide strategic safety input into \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;clinical trial designs, protocols, and regulatory submissions\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;1\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Establish and oversee \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;PV partnerships, vendors, and external collaborations\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Operational \u0026amp;amp; Regulatory Compliance\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;2\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Lead the\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;safety surveillance and signal detection process\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;, ensuring\u0026amp;nbsp;timely\u0026amp;nbsp;identification and mitigation of safety risks.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;2\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Oversee the preparation and submission of \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;safety reports (e.g., DSURs, PSURs, RMPs, SUSARs, IND safety reports, 15-day alerts)\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;2\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Ensure robust \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;case processing, signal evaluation, and risk management\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;processes are in place.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;2\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Represent the company in \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;regulatory interactions\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;regarding\u0026amp;nbsp;safety matters (FDA, EMA, etc.).\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Cross-Functional Collaboration\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;3\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Work closely with\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Clinical Development,\u0026amp;nbsp;Clinical Operations,\u0026amp;nbsp;Regulatory, Medical Affairs, and Commercial teams\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;to integrate safety considerations into decision-making.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;3\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Partner with \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Regulatory Affairs\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;to support new drug applications (NDAs) and marketing authorizations.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;3\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Support \u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;DSMBs, advisory boards, and investigator meetings\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;\u0026amp;nbsp;with safety\u0026amp;nbsp;expertise.\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Team Leadership \u0026amp;amp; Development\u0026lt;/span\u0026gt;\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;4\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;Build and lead a high-performing\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;pharmacovigilance team\u0026lt;/span\u0026gt;\u0026lt;span data-contrast=\u0026quot;auto\u0026quot;\u0026gt;, fostering a culture of scientific excellence and compliance.\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;li data-leveltext=\u0026quot;\u0026quot; data-font=\u0026quot;Symbol\u0026quot; data-listid=\u0026quot;4\u0026quot; data-list-defn-props=\u0026quot;{\u0026amp;quot;335552541\u0026amp;quot;:1,\u0026amp;quot;335559685\u0026amp;quot;:720,\u0026amp;quot;335559991\u0026amp;quot;:360,\u0026amp;quot;469769226\u0026amp;quot;:\u0026amp;quot;Symbol\u0026amp;quot;,\u0026amp;quot;469769242\u0026amp;quot;:[8226],\u0026amp;quot;469777803\u0026amp;quot;:\u0026amp;quot;left\u0026amp;quot;,\u0026amp;quot;469777804\u0026amp;quot;:\u0026amp;quot;\u0026amp;quot;,\u0026amp;quot;469777815\u0026amp;quot;:\u0026amp;quot;multilevel\u0026amp;quot;}\u0026quot; data-aria-posinset=\u0026quot;1\u0026quot; data-aria-level=\u0026quot;1\u0026quot;\u0026gt;Provide mentorship and guidance to internal safety professionals.\u0026lt;span data-ccp-props=\u0026quot;{}\u0026quot;\u0026gt;\u0026amp;nbsp;\u0026lt;/span\u0026gt;\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;div\u0026gt;\u0026lt;strong\u0026gt;Qualifications\u0026amp;nbsp;\u0026lt;/strong\u0026gt;\u0026lt;/div\u0026gt;\n\u0026lt;div\u0026gt;\n\u0026lt;ul\u0026gt;\n\u0026lt;li\u0026gt;Medical Degree (MD) in a life science–related field is required.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;15+ years of pharmacovigilance experience in the biopharmaceutical industry, including 10+ years in senior leadership roles.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated experience supporting CNS drug development programs across clinical and post-marketing stages.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Extensive experience in small molecule drug development (Phase 1–Phase 4).\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Proven track record of effective interactions with global health authorities on safety-related matters.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Deep understanding of global pharmacovigilance regulations, GVP, and ICH guidelines.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Demonstrated ability to lead safety risk management strategies, signal detection, and benefit–risk assessments.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Experience leading cross-functional safety teams and influencing stakeholders in a fast-paced biotech environment.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Expertise in clinical trial safety oversight, post-marketing pharmacovigilance, and regulatory safety submissions.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Strong analytical judgment, decision-making, and problem-solving capabilities.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Excellent written and verbal communication skills with the ability to engage senior internal and external stakeholders.\u0026lt;/li\u0026gt;\n\u0026lt;li\u0026gt;Ability to thrive in a dynamic, high-growth organization.\u0026lt;/li\u0026gt;\n\u0026lt;/ul\u0026gt;\n\u0026lt;/div\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Compensation\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The annual base salary range for this position is $350,000.00 to $380,000.00. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, and job knowledge.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;In addition to base pay, this role is eligible for a discretionary annual bonus.\u0026amp;nbsp;Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company-sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;Work Location\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;The Vice President, Pharmacovigilance and Safety role is based in the US, with occasional travel.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;POSITION:\u0026lt;/strong\u0026gt; Full-Time, Exempt\u0026lt;/p\u0026gt;\u0026lt;div class=\u0026quot;content-conclusion\u0026quot;\u0026gt;\u0026lt;p\u0026gt;EEOC Statement: Centessa Pharmaceuticals believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Centessa Pharmaceuticals will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;Please note: We will not assign referral rights for any unsolicited resumes from recruitment agencies.\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\n\u0026lt;p\u0026gt;\u0026lt;strong\u0026gt;\u0026lt;span class=\u0026quot;break-words\n          tvm-parent-container\u0026quot;\u0026gt;\u0026lt;img src=\u0026quot;https://centessa.hosted-by-files.com/CorpImages/Centessa_Pharmaceuticals_LLC_US_English_2026_Certification_Badge.png\u0026quot; alt=\u0026quot;Great Place to Work Certificate\u0026quot; width=\u0026quot;248\u0026quot; style=\u0026quot;max-width: 100%;\u0026quot;\u0026gt;\u0026lt;/span\u0026gt;\u0026lt;/strong\u0026gt;\u0026lt;/p\u0026gt;\u0026lt;/div\u0026gt;","departments":[{"id":4068209004,"name":"Clinical Development","child_ids":[],"parent_id":null}],"offices":[]}],"meta":{"total":10}}